3-Deazaguanine: report of a phase I trial and drug-related cardiac toxicity.
Margolin K, Doroshow J, Leong L, Akman S, Carr B, Odujinrin O, Flanagan B, Grove W, DeLap R, Goldberg D.
Margolin K, et al. Among authors: delap r.
Invest New Drugs. 1990 Nov;8(4):369-76. doi: 10.1007/BF00198593.
Invest New Drugs. 1990.
PMID: 2084070
Clinical Trial.